As part of our work to develop a new approach to ethics to help guide the work of the UK National Screening Committee (UK NSC), we tested the proposals by looking at family cascade screening for familial hypercholesterolemia (FH).
Prof Anne Slowther
Anne Slowther is Professor of Clinical Ethics at the University of Warwick, and a clinical ethicist at the University Hospital of Coventry and Warwickshire. Her clinical background is in general practice. She co-leads the values, law and ethics teaching in the MBChB curriculum at Warwick. Her research on clinical ethics committees in the UK in the early 2000s led to the establishment of the UK Clinical Ethics Network and she continues to be a member of the Network’s Board of Trustees. She is a member of the Board of Trustees of the Institute of Medical Ethics and has contributed to working groups advising the UK Advisory Committee on the safety of blood tissue and organs (SaBTO) on policy recommendations.
Details of the public dialogue, commissioned by the UK NSC, Genomics England and the UKRI's Sciencewise programme, to understand the views of the public about the potential use of whole genome sequencing in newborn screening.
Related content and links
About this blog
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
Comments and moderation
- Work starts on reviewing the case for screening for SMA November 11, 2022
- The role of patient and public voice members on the UK NSC November 8, 2022
- Why evidence maps are the UK NSC’s first step in reviewing screening evidence October 28, 2022